The Journal of Molecular Diagnostics (JMD) publishes high-quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The impact factor is 4.426.*
Articles report novel discoveries with direct application to clinical diagnostics or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; and the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition.
Special Features include Technical Advances, a peer-reviewed section featuring novel methods to solve diagnostic dilemmas. Reviews, Commentaries, and Special Articles provide focus on controversial or "hot" research topics and issues.
Starting in 2020 JMD is increasing publication to release 12 issues per year!
New submissions to The Journal of Molecular Diagnostics should be submitted on the Editorial Manager submission and review platform.
*Thomson Reuters Citation Report 2018
Barbara Zehnbauer, PhD
Emory University School of Medicine
JMD is co-owned by ASIP with the Association for Molecular Pathology (AMP), and published by Elsevier
JMD Online (Member Access)
JMD Online (Non-Member Access)
Contact the Editorial Office: firstname.lastname@example.org
JMD iPad app now available! Updated FREE benefit to members and journal subscribers. Click here for access instructions and details.